Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 26;17(6):e86793.
doi: 10.7759/cureus.86793. eCollection 2025 Jun.

Searching for Clues in the Diagnosis of McArdle Disease

Affiliations

Searching for Clues in the Diagnosis of McArdle Disease

Sanem Pinar Uysal et al. Cureus. .

Abstract

Introduction McArdle disease (glycogen storage disorder type 5) is an autosomal recessive metabolic myopathy caused by a myophosphorylase enzyme deficiency. Most patients develop symptoms during childhood; however, diagnosis is usually delayed until adulthood. Our study aimed to identify clues for an earlier recognition of this rare disease. Materials and methods This is a retrospective case series of 15 patients with McArdle syndrome, as diagnosed histologically and/or genetically, who were evaluated at the Cleveland Clinic Neurologic Institute. Data related to demographics, symptoms, exam findings, laboratory test results, genetic testing, muscle biopsy, and prior misdiagnoses were analyzed. Results Fifteen patients with McArdle disease were identified with a median age at symptom onset of 20 years (IQR=11.5-31.25). Symptoms included exertional myalgia and fatigue in all patients (n=15) and the second wind phenomenon in 53% (n=8). Creatine kinase (CK) values were elevated in 930/931 measurements (range 273-75510 IU/L), and myoglobinuria was seen in 60% (n=9). All patients exhibited significant fluctuations in CK, defined as a maximum-to-minimum ratio greater than 5 (ratio range: 5.4-276.6, median ratio: 20.4). Electromyographies (EMGs) were normal in 33% (n=5/15). Median age at diagnosis was 34 years (IQR=28-42). Median delay in diagnosis was 11 years (IQR=5-17). Ten patients (67%) were initially misdiagnosed, and the most common misdiagnosis was autoimmune myositis (n=5, 33%). Conclusions A lack of or underreporting of myoglobinuria or the second wind phenomenon by the patients can lead to a delay in the diagnosis of McArdle disease. Persistently elevated baseline CK without objective weakness and at times dramatically fluctuating CK levels are important diagnostic clues. Physical exam and EMG are often non-diagnostic. Increased awareness of this condition is critical to avoid misdiagnoses.

Keywords: elevated ck; glycogen storage; glycogen storage disorder; mcardle disease; metabolic myopathy; non-traumatic rhabdomyolysis; second wind phenomenon.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Cleveland Clinic Institutional Review Board issued approval 22-978. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Stereotypical CK fluctuations over time, CK max/min >5
(A) CK fluctuation for patient ID4 over nine years. (B) CK fluctuation for patient ID7 over 1.5 years. CK: creatine kinase

References

    1. Muscle glycogenoses: an overview. Di Mauro S. https://pmc.ncbi.nlm.nih.gov/articles/PMC2949320/ Acta Myol. 2007;26:35–41. - PMC - PubMed
    1. McArdle disease: molecular genetic update. Andreu A, Nogales-Gadea G, Cassandrini D, Arenas J, Bruno C. https://pmc.ncbi.nlm.nih.gov/articles/PMC2949323/ Acta Myol. 2007;26:53–57. - PMC - PubMed
    1. Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data. De Castro M, Johnston J, Biesecker L. Genet Med. 2015;17:1002–1006. - PMC - PubMed
    1. The second wind in McArdle patients: fitness matters. Salazar-Martínez E, Santalla A, Valenzuela PL, et al. Front Physiol. 2021;12:744632. - PMC - PubMed
    1. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. Vissing J, Haller RG. N Engl J Med. 2003;349:2503–2509. - PubMed

LinkOut - more resources